Navigation Links
Antivirals reduce deaths from flu in hospitalized patients

Adults with influenza infections serious enough to require hospitalization are much less likely to die from the disease if they are given antiviral medications, according to a new study published in the December 15 issue of Clinical Infectious Diseases, currently available online. While previous clinical trials have shown the antiviral benefit in a relatively young, healthy adult population if they were treated within 48 hours of the onset of flu symptoms, this study showed a significant benefit to an older population even when given antivirals three or four days after the appearance of flu symptoms.

Influenza is a disease contracted by between 5 percent and 20 percent of the US population each year. Annually, more than 200,000 Americans are hospitalized with the flu and about 36,000 die from the disease. Older people and young children are at higher risk for serious flu complications.

Influenza causing hospital admission is more common than most people think. We will save lives if we recognize and appropriately treat influenza in patients being admitted to the hospital, said lead author Allison McGeer, MD.

This study was conducted by Dr. McGeer and colleagues from the Mount Sinai Hospital, the University of Toronto, and the Toronto Invasive Bacterial Diseases Network. They analyzed data from 327 adults who were hospitalized for influenza between January 2005 and May 2006. Approximately one-third of the patients received antiviral therapy. Treatment with antivirals reduced the risk of death by nearly 80 percent.

It is notable that many of the patients who received antiviral medication three or four days after the appearance of flu symptoms seemingly benefited. Previous research has shown that in otherwise healthy adults, influenza virus is cleared quickly by the bodys immune response and antiviral therapy given more than 48 hours after the onset of symptoms is unhelpful. The authors note that some of their patients may have been immunocompromised for non-flu related reasons and might therefore retain the virus longer than healthy patients. Another possibility is that patients who require hospital admission for influenza are a small subgroup of the people who get infected. These patients may have trouble controlling the virus and thus develop more serious, more prolonged illness.

This research supports the use of antiviral medications to treat people hospitalized with influenza. Antiviral medications are very safe, have no significant drug interactions, and relatively few side effects, said Dr. McGeer. You dont, however, want to take them if you dont need them. As with antibiotics, there is a risk of selection for antiviral resistance and it is important to use the medications only where there is a clear benefit.

The authors do not want to diminish the value of influenza vaccines. There is a great deal of data proving that vaccine is effective and cost-effective, added Dr. McGeer. Our data simply say that despite the substantial reductions in death and illness associated with vaccine use, considerable morbidity and mortality due to influenza remain. We needand people are working onbetter vaccines; until we get them, we can help people by diagnosing and treating disease.


Contact: Steve Baragona
Infectious Diseases Society of America

Related medicine news :

1. New study: Pine bark reduces perimenopausal symptoms
2. Different method of evaluating the urinary tract system reduces radiation dose
3. Saline Reduces Mortality for Brain Injury Patients
4. New approaches to reduce scarring
5. Fruity vegetables and fish reduce asthma and allergies
6. New study: Pine bark extract reduces ADHD symptoms in children
7. New Case Study Details How an Illinois Hospital Created a Safe Lifting Team that Dramatically Reduced Injuries, Increased Staff Satisfaction
8. Giving emergency nurses aromatherapy massages with music dramatically reduced stress levels
9. Radiation therapy technique reduces length of prostate cancer treatment
10. Radiation therapy technique reduces length of prostate cancer treatment
11. Giving emergency nurses aromatherapy massages with music dramatically reduced stress levels
Post Your Comments:
(Date:11/28/2015)... Aliso Viejo, CA (PRWEB) , ... November 28, 2015 , ... ... 30 new fully customizable media panels to choose from, the possibilities are endless. Users ... angle, and more. With the ProPanel: Pulse masking effects, users are sure to get ...
(Date:11/27/2015)... CO (PRWEB) , ... November 27, 2015 , ... According ... cities are not changing the way that they are handling security in light of ... police and security presence in an attempt to stop an attack from reaching U.S. ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... were," said an inventor from Hillside, N.J. "Many people catch diseases simply from ... that individuals will always be protected from germs." , He developed the patent-pending ...
(Date:11/27/2015)... ... , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of ... than 3.7 billion people under the age of 50 – or 67% of the population ... global estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... Secura Consultants has prided itself for not only fulfilling the needs of advisers ... solutions at an affordable price and providing top-tier customer service. However, there's always ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... addition of the "Radioimmunoassay Market by ... (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), ... Global Forecast to 2020" report to ... has announced the addition of the ...
(Date:11/25/2015)... 25, 2015  Amgen (NASDAQ: AMGN ) today ... with the United States (U.S.) ... biosimilar candidate to Humira ® (adalimumab). Amgen believes ... to the FDA and represents Amgen,s first BLA submission ... Harper , M.D., executive vice president of Research and ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
Breaking Medicine Technology: